Machine learning (ML) is a domain of artificial intelligence that allows computer algorithms to learn from experience without being explicitly programmed. OBJECTIVE: To summarize neurosurgical applications of ML where it has been compared to clinical expertise, here referred to as "natural intelligence. " METHODS: A systematic search was performed in the PubMed and Embase databases as of August 2016 to review all studies comparing the performance of various ML approaches with that of clinical experts in neurosurgical literature. RESULTS: Twenty-three studies were identified that used ML algorithms for diagnosis, presurgical planning, or outcome prediction in neurosurgical patients. Compared to clinical experts, ML models demonstrated a median absolute improvement in accuracy and area under the receiver operating curve of 13% (interquartile range 4-21%) and 0.14 (interquartile range 0.07-0.21), respectively. In 29 (58%) of the 50 outcome measures for which a P-value was provided or calculated, ML models outperformed clinical experts (P < .05). In 18 of 50 (36%), no difference was seen between ML and expert performance (P > .05), while in 3 of 50 (6%) clinical experts outperformed ML models (P < .05). All 4 studies that compared clinicians assisted by ML models vs clinicians alone demonstrated a better performance in the first group. CONCLUSION: We conclude that ML models have the potential to augment the decisionmaking capacity of clinicians in neurosurgical applications; however, significant hurdles remain associated with creating, validating, and deploying ML models in the clinical setting. Shifting from the preconceptions of a human-vs-machine to a human-andmachine paradigm could be essential to overcome these hurdles.
programmed. 4, 5 ML methods are already widely applied in multiple aspects of our daily lives, although this is not always obvious to the casual observer; common examples are email spam filters, search suggestions, online shopping suggestions, and speech recognition in smartphones. 3 Artificial intelligence by means of ML is entering the realm of medicine at an increasing pace and has been tested in a variety of clinical applications ranging from diagnosis to outcome prediction. 6, 7 ML algorithms in general can be divided into supervised, unsupervised, and reinforcement learning algorithms, and each algorithm has its own mathematical structure (Table 1) . [5] [6] [7] Reinforcement learning algorithms aim to determine the ideal behavior within a specific context based on simple reward feedback on their The nodes in the input layer and output layer represent the input features and target outputs, respectively
The nodes in the "hidden" and output layers base the value of their output on the total input they receive Can model very complex relationships between input features and output No need to model the underlying data generating mechanism
Robust to noise and incomplete data Difficult to interpret the explicit relationships between input features and outcome Prone to overfitting Long training times Requires significant memory and processing power for large data sets SVM-supervised learning SVMs classify data points on their input features by calculating the ideal "separating hyperplane"
SVMs select the hyperplane with the maximal distance to the nearest data point, "support vectors"
A kernel function is mathematical trick that adds an extra dimension to the data Nonseparable 2-dimensional data, for example, could then be separated in a 3-dimensional space Can model very complex relationships between input features and output
Effective in high-dimensional data Robust to noise and overfitting Fast fitting procedure Difficult to interpret the explicit relationships between input features and outcome Choosing a kernel function is a tuning parameter Requires significant memory and processing power Decision tree-supervised learning Decision trees make predictions or classifications based on several input features with the use of bifurcating the feature space At each split of branches, training examples are divided based on class or value of the specific feature
In ML, algorithms are used to find optimal features at which a split is made and the optimal value in case of a numeric feature Easy to interpret Fast Robust to noise and incomplete data Generally high accuracy performance among competitors Complex trees are hard to interpret Small variation in data can lead to different decision trees Does not work very well on a small training data set Prone to overfitting KNN-supervised learning The algorithm compares a data point with unknown class to its K nearest neighbors, and determines its class as the most common class of its neighbors
For the value K = 1, the algorithm compares the example with the single closest neighbor Easy to interpret Classes do not need to be linearly separable Naturally handles multiclass classification and regression Robust to noisy training data Computation only required at the time of evaluation Performs poorly on high dimensionality datasets Must define a meaningful distance function (distance function determines which neighbors will be considered closest)
The value of K has a large effect on the behavior of this model. Naïve Bayes-supervised learning Naïve Bayes calculates the most likely output based on the input features and the a priori chance.
The probability of a certain outcome is the product of probabilities given by the individual features It assumes that the presence (or absence) of a feature is unrelated to the presence of any other feature
Easy to interpret
Easy to construct Fast Robust to overfitting Performs less in low-dimensional data It assumes that the presence of a feature is independent of the presence of other features, which rarely is the case in life actions; the self-driving car is a typical example. Reinforcement learning is, however, beyond the scope of the current review. Supervised learning algorithms are trained on prelabeled data referred to as the training set. 7 This training process is an iterative process in which ML algorithms try to find the optimal combination of variables and weights given to the input variables (referred to as features) of the model with the goal of minimizing the training error as judged by the difference between predicted outcome and actual outcome. 6 A model with high error due to bias can fail to capture the regularities in the data, resulting in an inaccurate model underfitting the data. Increasing the complexity of the model, such as adding more parameters in the model, can reduce this bias. However, an excessively complex model, such as having too many parameters compared to the number of patients, can describe random error or noise instead of the meaningful relationships, referred to as overfitting of the data. This results in an increase in error due to variance and a reduced generalizability to previously unseen data. The complexity of a model should, therefore, be a tradeoff between bias and variance. 3 To avoid overfitting, predictive models must be validated on a test set that was not involved in the training process.
For unsupervised learning techniques on the other hand, no prelabeling is required. These algorithms cluster data points based on similarities in features and can be powerful tools for detecting previously unknown patters in multidimensional data. 6 The progress in this field of applied ML is continuously driven by the growing amount of available data and the increasing computational power. 8, 9 ML is increasingly tested in neurosurgical applications and even demonstrated to emulate the performance of clinical experts. The complex diagnostic and therapeutic modalities employed in neurosurgery provide a rich assortment and quantity of data towards construction of ML models. The primary aim of this systematic review is to compare the performance of ML and clinical experts head-to-head in applications relevant to neurosurgery providing insights into the current state of advancement of ML and its potential to improve clinical decision making. The secondary aim is to discuss hurdles in creating, validating, and deploying ML models in the clinical setting. To our knowledge, this is the first systematic review comparing the performance of natural intelligence (clinical experts) and artificial intelligence (ML) in neurosurgery, but this review could offer valuable insights for other surgical and nonsurgical specialties too.
METHODS
A systematic search in the Pubmed and Embase databases has been performed according to the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines, to identify all potential relevant studies as of August 2016. The search syntax was built with the guidance of a professional librarian using search terms related to "Artificial intelligence" and "Neurosurgery." The exact search syntax for the Pubmed and Embase databases is provided in Table, Supplemental Digital Content.
Studies were included that compared ML models against clinical experts in applications relevant to the neurosurgical patient population, comparing them head-to-head to a third modality defined as the "ground truth." We defined the neurosurgical patient population as patients eligible for neurosurgical treatment throughout the course of the disease. No specific limitation was applied regarding the domain of application (including diagnosis, prognosis, treatment, and outcome prediction) to be as comprehensive as possible. The definition of "ground truth" depends on the specific task evaluated in the study and could include actual survival in a survival prediction task, [33] [34] [35] histological diagnosis in a radiological diagnostic classification task, [36] [37] [38] [39] [40] or consensus of a panel of experts when no "objective third modality" is available. 33, 41, 42 Exclusion criteria were lack of full text, languages other than English and Dutch, animal studies, and absence of a third modality as ground truth when comparing ML and experts. The study selection and data collection was done by 2 independent authors (JS, AK). Disagreements were solved by discussion, in which 2 other authors were involved (OA, HD).
Data extracted from each study were (a) year of publication, (b) disease condition, (c) specific application, (d) ML model used, (e) input features, (f ) size of training set, (g) validation method, (h) size of test set, (i) (sub)specialization of clinical experts, (j) level of education of clinical experts, (k) ground truth, (l) statistical measure of performance, (m) performance of ML models, (n) performance of clinical experts, and (o) P-value of the difference in performance. We considered a quantitative synthesis to be inappropriate due to the heterogeneity in neurosurgical applications. A qualitative synthesis of results and assessment of risk of bias on outcome, study, and review level is provided by means of a narrative approach. However, to summarize the findings in some quantitative form, the median absolute improvement was calculated for the most commonly used statistical measures of performance, accuracy, and area under the receiver operating curve (AUC). Accuracy refers to the proportion of correct predictions among the total number of predictions, and the AUC corresponds to the probability that a binary classifier will rank a randomly chosen positive instance higher than a randomly chosen negative. The proportion of superior/equal/inferior performance was calculated in percentages. Superior performance is defined as a significantly better performance (P < .05) according to the statistical measure used for evaluation. Equal performance was defined as a nonsignificant difference in performance (P > .05). P-values were calculated manually if they were not reported in the papers. Fisher's exact test was used for outcome measures with a binomial distribution (accuracy, sensitivity, specificity, positive predictive value, negative predictive value). Student's t-test was used to compare continuous outcome measures. Bound continuous outcome scores, such as the F-measure or AUC (both range 0-1), were transformed to unbound scores (range 0-infinity) using a delta method to meet the assumptions of the Student's t-test. When multiple ML models and/or multiple clinicians were compared, the mean performances were used to calculate the P-value.
RESULTS
After removal of duplicates, a total of 6052 citations in the Pubmed and Embase databases were identified. Forty-four potential relevant studies were selected by title/abstract screening, of which 23 studies remained after full-text screening that evaluated a total of 34 ML models and compared their performance to that of clinical experts based on a total of 61 outcome measures ( Figure) .
Study Characteristics
The median size of the training set was 79 patients (range 9-7769; interquartile range [IQR] 36.5-123). The median size of the test set was 124.5 patients (range 29-1225; IQR 34.5-139.4). Ten studies used cross-validation methods only instead of a separate test set. 36, 37, [39] [40] [41] [43] [44] [45] [46] [47] The median ratio between the size of the training set and size of the test set was 1:0.96 (range 1:0.01-1:1.63; IQR 1:0.50-1:1.40).
Twenty-one studies evaluated supervised learning algorithms, and 2 studies evaluated unsupervised learning algorithms. 33, 55 Of the various ML models used, artificial neural networks (n = 13) [35] [36] [37] [38] [39] [40] 42, 45, [48] [49] [50] 52, 54 and support-vector machines (n = 6) 34, 38, 41, 44, 49, 51 were the most frequently used algorithms. Other learning algorithms used were decision tree (n = 2), 38, 49 linear discriminant analysis (n = 2), 42 ,43 fuzzy C-means (unsupervised learning; n = 2), 33, 55 deep learning (n = 1), 41 quadratic discriminant analysis (n = 1), 46 linear regression (n = 1), 52 naïve Bayes (n = 1), 47 and genetic algorithm (n = 1). 49 The clinical experts were neurosurgeons, 35, 44, 53 neurologists, 46, 47 (neuro)radiologists, 33, 34, 36, 37, 39, 40, 44, 46, 52, 55 neurophysiologists, 51 emergency medicine physicians, 48 and hospital hygienist physicians 53 with different levels of education and/or subspecialty.
Ground truth was established by another diagnostic modality, 33, 36, 37, 39, 40, 44, 46, 48, 52 clinical outcome, [33] [34] [35] 47, 49 expert agreement, 33 ,41,55 database information, 43 or a combination of these sources.
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Descriptive Summary of Results
The performance of ML models was compared to clinicians in 23 studies evaluating their utility for diagnosis, preoperative planning, and outcome prediction on a total of 61 outcome measures. The most frequently used statistical measures of performance were accuracy (48% of the studies and 22% of the outcome measures) and AUC (43% of the studies and 21% of the outcome measures). Compared to the clinical experts, the median absolute improvement of the prediction accuracy and AUC of the ML models was 13% (range -4% to 38%; IQR 4%-21%) 35 [33] [34] [35] [38] [39] [40] 44, 48, 50, 54 respectively. A P-value was provided for 25 and manually calculated for another 25 of the 61 outcome measures. In 29 of 50 (58%), ML models outperformed clinical experts (P < .05). In 18 of 50 (36%), no significant difference was seen between ML and expert performance. In 3 of 50 (6%), clinical experts outperformed ML models (P < .05). All studies could be divided into 3 domains of applications: diagnosis, preoperative planning, and outcome prediction. Results on the performance of ML models and clinical experts are provided for each study in Table 2 . Methodological details are provided for each study in Table 3 . Statistical measures used for the evaluation of performance are explained in Table 4 .
Diagnosis
Fourteen studies compared ML and experts on diagnostic performance. 33, [36] [37] [38] [39] [40] 43, 44, 48, [50] [51] [52] [53] [54] Four studies focused on diagnostic classification of pediatric posterior fossa tumors, 36, 37 intra-axial tumors, 40 or sellar-suprasellar masses. 39 All 14 studies used age and magnetic resonance imaging (MRI) scans as input features with or without additional clinical input (age, gender, medical history, symptoms, signs, and/or family history) 36, 37, 40 or radiological input (computed tomography (CT), magnetic resonance spectroscopy).
36,37 ML methods were compared against the performance of neuroradiologists 36, 37, 39 and/or general radiologists. 39, 40 ML models performed significantly 36 and nonsignificantly 37 better in differentiating pediatric posterior fossa tumors. Two studies compared the performance of clinicians assisted by ML models against clinicians alone. ML models significantly increased the AUCs for the classification of suprasellar masses in general radiologists (0.88-0.98; P = .008) and neuroradiologists (0.95-0.99; P = .04). 39 Also, ML improved the diagnostic classification of intracerebral tumors by radiologists (AUC 0.90-0.95; P < .001). 40 Five studies attempted to predict World Health Organization (WHO) grade in gliomas based on MRI features alone 33, 38, 52, 54 or in combination with age. 44 ML models were compared against neuroradiologists, 33, 44, 54 general radiologists, 38, 52 and/or neurosurgeons. 44 ML models performed significantly 38, 44, 54 and nonsignificantly 33, 38, 44, 52 better in predicting WHO grade in gliomas.
ML showed a significantly higher AUC in differentiating single-photon emission computer tomography images with brain lesion from images without brain lesions. 50, 56 Three studies evaluated the diagnostic application of ML models without the use of radiological input features. 43, 48, 53 ML showed a significantly higher accuracy in differentiating single-cell and multiunit spike clusters based on intracranial electroencephalography in epilepsy patients. 43 ML using clinical input features had a significantly higher accuracy in predicting the presence of CT abnormalities in pediatric traumatic brain injury (TBI) patients compared to pediatric emergency medicine fellows and residents. 48 In a study that used natural language processing (NLP) to identify surgical site infections from free text of electronic health records (EHR), a significantly higher sensitivity and F-measure and lower positive predictive value was found for the NLP method compared to a neurosurgeon and/or hospital hygienist physician. 53 NLP is a technique used to process written text such that it may be used to generate MLbased predictive models. 57, 58 This tool is especially important when analyzing the large amount of free-text data inherit to the EHR. 47, 53 
Preoperative planning
Seven studies compared ML and experts for performance in preoperative planning. 33, 41, 42, [45] [46] [47] 55 Tumor segmentation is used for neurosurgical planning to extract the 3-dimensional shape of the tumor from an MRI scan and its relationship with the surrounding anatomy. ML-based MRI segmentation was compared against manual segmentation by (neuro)radiologists in 3 studies, of which 2 evaluated glioma segmentation 33, 55 and 1 brainstem segmentation. 41 Comparison consisted of assessing the similarity in the classification of individual voxels by both manual and automated methods. Consensus of multiple experts was considered as the ground truth. ML showed a significantly higher dice similarity coefficient with ground truth and a lower percentage of volume difference for brainstem segmentation. 41 Furthermore, median segmentation speed was 36 to 40 s instead of 20.2 min. ML models had a significantly higher sensitivity for the segmentation of low-grade gliomas and high-grade gliomas at the cost of a lower PPV. 33 In another study evaluating glioma segmentation, the correlation coefficient with ground truth was significantly higher for ML compared to 2 out of 3 experts. 55 Four studies evaluated epileptogenic zone localization tasks. 42, 45, 46, 49 ML demonstrated a significantly higher accuracy in differentiating left-sided temporal lobe epilepsy (TLE) and right-sided TLE based on functional MRI. 46 No significant difference was found in differentiating TLE from extratemporal lobe epilepsy based on symptoms and genetic information. 49 ML models performed similarly to human experts in localizing the epileptogenic zone by means of positron emission tomography Abbreviations: ANN: artificial neural networks; CT: computer tomography; DL: deep learning; DT(C4.5): decision tree (C4.5 is type of DT); GA: genetic algorithm; ICD: international classification of disease; LDA: linear discriminant analysis; LOOCV: leave-one out cross validation; LR: linear regression; FCM: fuzzy c-means; FCV: fold cross validation; FDG-PET: positron emission tomography using fludeoxyglucose; NA: not available; NB; naïve bayes; NLP: natural language processing; NOS: not otherwise specified; QDA: quadratic discriminant analysis; SVM: support vector machines; VEEG: video electroencephalography monitoring test; -: not applicable a This study also measured performance of clinical experts that used ML as second opinion.
TABLE 4. Statistical Measures Explained
Accuracy Proportion of correct predictions among the total no. of predictions (TP + TN)/total population; range 0% to 100% Sensitivity Proportion of positively classified cases among the total no. of positive cases; TP/(TP + FN); range 0% to 100% Specificity Proportion of negatively classified cases among the total no. of negative cases; TN/(TN + FP); range 0% to 100% Positive predictive value Proportion of positive cases among the total no. of positively classified cases; TP/(TP + FP); range 0% to 100% Negative predictive value Proportion negative cases among the total no. of negatively classified cases; TN/ (TN + FN) ; range 0% to 100%
Positive likelihood ratio
Refers to the increase in probability if the condition of the test is positive; Sens/(1 -Spec); range 1 to ∞ Negative likelihood ratio
Refers to the decrease in probability if the condition of the test is positive (1 -Sens)/Spec; range 0 to 1 F-measure Measure of accuracy that uses the sensitivity and positive predictive value (2 × TP)/(2 × TP + FP + FN); range 0 to 1 Area under the ROC curve ROC is a graphical plot illustrating the sensitivity as a function of "1 -specificity" in a binary classifier with a varying discrimination threshold. The area under the curve corresponds to the probability that a binary classifier will rank a randomly chosen positive instance higher than a randomly chosen negative one; range 0 to with fludeoxyglucose; however, combining the 2 improved the classification accuracy significantly. 45 One study showed that ML-based NLP could identify surgical candidates among pediatric epilepsy patients. NLP methods used data of free-text clinical notes extracted from the EHR as input feature. Actual surgery as reported in the EHR was considered as ground truth. The F-measure was higher than that of pediatric epileptologists at time of referral (0.78-0.82 vs 0.71) and even 12 mo before referral (0.74).
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Outcome Prediction
Three studies evaluated outcome prediction. [33] [34] [35] Two studies evaluated survival prediction in glioma patients based on MRI features. 33, 34 One study provided P-values, showing significantly higher AUCs for 6-mo, 1-, 2-, and 3-yr survival compared to a neuroradiologist. 34 One study evaluated in-hospital survival prediction in TBI patients based on clinical features. Compared to the neurosurgeons and/or neurosurgical residents, the ML models performed superiorly on accuracy, sensitivity, and AUC and performed equally on specificity.
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DISCUSSION
The aim of this systematic review was to compare the performance of ML and clinical experts head-to-head in applications relevant to neurosurgery, providing insights into the current state of advancement of ML and its potential to improve clinical decision making. Compared to the clinical experts, the median absolute improvement of the prediction accuracy and AUC of the ML models was 13% and 0.14, respectively. In 29 of 50 (58%) studies that provided a P-value or sufficient details to calculate a P-value, ML models outperformed clinical experts significantly (P < .05). Our results show that ML models can emulate the performance of clinicians in some neurosurgical applications within the domains of diagnosis, preoperative planning, and outcome prediction.
Implications of Implementing ML in Neurosurgical Care
Although the output consisted of a wide range of neurosurgical applications, ML was most frequently used for analyzing radiological data by means of artificial neural networks. Since every voxel can be used as an individual input feature, the amount of information that can be extracted by ML is extremely high, making it faster and more accurate than is humanly possible. Automated analysis of radiological data for diagnosis, segmentation, or outcome prediction could, therefore, be one of the first ML applications that finds its way to actual clinical practice. 2 Due to the vast amount of radiological data, the total amount of data remains high even in smaller sample sizes. The median size of training sets across all studies was relatively low (79 patients); however, many studies were still able to construct highperforming ML models using radiological data. The training of ML models is, therefore, dependent on both the sample size and the volume of data collected per patient.
An important preconception regarding the role of ML models in the clinical realm is that it would result in displacement of clinicians, the so-called human-vs-machine paradigm. In reality, even if ML models are able to perform a given analysis with very high accuracy, clinicians still must consider the implications of this analysis in the global sense. The results of an ML model are better utilized to augment the clinician in medical decision making, which we refer to as human-and-machine. As an example, 4 studies assessed the combined performance of clinicians and ML models for radiological diagnosis or segmentation. 39, 40, 45, 54 In all studies, ML in conjunction with clinical decision making was superior to clinical decision making or ML models alone. This highlights the fact that both ML models and human experts contribute to the classification task and are, therefore, complementary to each other.
Although ML can be a very powerful tool for clinicians to make sense of and use big data and even emulate clinical expertise, it remains ambiguous how these methods should be implemented in actual clinical practice. In 2 studies that used a human-andmachine approach, radiologists used ML models as a second opinion for radiological diagnosis, 39, 40 whereas the radiologist's impression was used as an ML input feature in the other 2 studies. 45, 54 In both cases, ML is used to increase diagnostic accuracy. On the other hand, ML can also be used to increase efficiency of clinicians by automating clinical decision making and select cases that need secondary evaluation. Lastly, ML can produce error detection systems for clinicians (in training), operating on the background only.
Challenges Regarding the Implementation of ML Models
A barrier with the introduction of ML models into clinical practice is that the mechanisms driving the algorithms can be very complex, or even impossible, to interpret; as such, these algorithms are sometimes referred to as "black box" techniques. This contrasts with most of the conventional statistical methods, such as regression coefficients, odds ratios, or hazard ratios that are familiar and can be easily interpreted for clinical meaning. This creates a conflict where on one hand we have powerful predictive algorithms, and on the other hand our inability to peer inside the "black box" can result in adoption hesitancy. We suspect that as more ML models are produced and validated and as such become more familiar, clinicians will be more comfortable deploying them in daily practice.
Another hurdle is that the generation of ML model requires a large amount of complete and adequately categorized data. Due to higher quality data, the performance of ML models could be overestimated in research setting compared to their true performance in the clinical setting. Lastly, access to patient data, especially across institutions, is rightfully restricted given privacy considerations, which can cause difficulties in obtaining highvolume training data sets.
To overcome these challenges, more studies should take a human-and-machine approach to explore how clinicians can benefit most from the powerful analyses that ML offers. This means, for example, assessing the diagnostic performance and efficiency of radiologists assisted by an ML automated diagnosis system or assessing surgical outcomes after operations that have been planned with the use of ML segmentation models. Furthermore, future studies should focus on creating an ethical and legal framework that supports collection of training data, validation of ML models on heterogeneous test sets prior to deployment, and regulation of the ML performance after deployment in clinical care.
Limitations
This review has some inherent limitations. It is possible that the ML models reviewed here are being compared to clinical experts in situations where ML models are more likely to perform superiorly. Due to positive publication bias, the performance of ML could be overestimated even more. This review is limited to situations where human decision making and ML methods are comparable, ignoring the potential of ML methods on tasks that lie beyond the capacity of human experts. Furthermore, most studies evaluated performance in terms of precision and accuracy, and only 1 study evaluated clinicians and ML models based on the speed of performing a classification/prediction task. 41 This underexposes the potential in which computers perform at their best: taking over very simple and repetitive tasks at a much higher speed. Additionally, the performance of clinical experts could be overestimated when ground truth is defined as a consensus of multiple experts; the individually tested experts could be influencing that ground truth.
Another weakness to a systemic analysis is that most outcome measures did not provide a P-value; however, we have calculated P-values manually for 25 outcome measures, and these outcome measures were also represented in the median absolute difference in accuracy and AUC, demonstrating similar results in favor of the ML models (Table 2 ). Summarizing the results based on outcome level does not provide the adequate weight that should be given to each study based on the size and quality of the study. Many studies only used cross-validation without a distinct test set when creating the ML model. [35] [36] [37] [39] [40] [41] [43] [44] [45] [46] [47] Cross-validation divides the original data in training and test data multiple times, and the validation results are averaged over the number of rounds. This could overestimate the performance of ML models as the data is used for both training and selection of the model. Some studies assess multiple outcome measures that are interrelated, resulting in an overrepresentation of the findings in these studies. 34, 44 Nevertheless, we deem the limitations proportionate to the strength of this systematic review. This review provides a thorough overview of ML models in neurosurgical applications. To our knowledge, this is the first systematic review comparing the performance of ML models with that of clinical experts in neurosurgery. By using the performance of clinical experts as a benchmark, this review provides valuable insights into the current state of advancement of artificial intelligence in neurosurgery and its future role in patient care. Lastly, it identifies hurdles to overcome in creating, validating, and deploying ML models in the clinical setting.
